Yahoo Web Search

Search results

1. • 

     BTK Inhibitor Likely to Get a Pass to Phase III in Uncontrolled Asthma

     MedPage Today· 1 day ago

     Treatment with an investigational oral Bruton's tyrosine kinase (BTK) inhibitor was associated with...

2. • 

     Asthma Triggers In Homes Can Send Kids to the ER—This Organization Is Working to Change That

     Health.com· 4 days ago

     For parents of children with asthma, witnessing an attack of severe symptoms can be a terrifying...

3. • 

     GSK’s asthma drug shows promise in reducing severe attacks

     WSAU Wausau· 4 days ago

     (Reuters) - GSK's asthma drug met its primary goal of reducing asthma attacks over a 52-week period...

4. • 

     Eosinophilic Asthma

     Health via Yahoo News· 6 days ago

     Consider the following: Being 35-50 years old Having a personal or family history of asthma or other allergic conditions Smoking tobacco Diagnosis If you...

5. • 

     GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows

     Benzinga via Yahoo Finance· 4 days ago

     Tuesday, GSK plc (NYSE:GSK) released headline results from the phase III clinical trials SWIFT-1 and...

6. • 

     Potentially severe storms possible around Philadelphia, Jersey Shore on Monday

     CBS News· 2 hours ago

     Almost ideal weather conditions will start off the Memorial Day weekend around Philadelphia and the...

7. • 

     GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals

     Zacks via Yahoo Finance· 3 days ago

     GSK’s GSK two-phase III studies, which evaluated depemokimab for treating severe asthma...

8. • 

     GSK boasts win for depemokimab in asthma trials

     Clinical Trials Arena via Yahoo Finance· 4 days ago

     The two randomised, multi-centre, placebo-controlled trials investigated depemokimab in adults and adolescents with severe asthma with type 2...

9. • 

     Research finds few moderate or severe asthma patients prescribed recommended inhaler regimen

     Medical Xpress· 4 days ago

     In the United States, ICS-formoterol inhalers include Symbicort (budesonide-formoterol) and Dulera...

10. • 

      GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial

      The Wall Street Journal· 4 days ago

      Depemokimab could be the first approved drug to allow a long-term dosing interval, requiring only...